Licensed Practical Nurse in Bothell, WA Accepting Medicare

9 Licensed Practical Nurse nurses found. Showing 1 - 9

Regina Howard, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 425-672-7293

Craig Bertram, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 425-527-0477

Rhodora Guinto, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 108 181st St Sw, Bothell, WA 98012 Phone: 206-334-6169

Mrs. Luanne Mignon Murro-te, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 425-672-7293    Fax: 425-329-4640

Mrs. Mandy Lee Mcneil, LP6002170 Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 425-627-7293    Fax: 425-329-4640

Sunday Thursten, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 19221 90th Pl Ne, Bothell, WA 98011 Phone: 206-650-3077

Cindy Marie Doop, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 877-941-8957

Melissa Jo Harper, LP60732505 Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se Ste 101, Bothell, WA 98021 Phone: 425-672-7293    Fax: 425-329-4640

Ms. Rachel Leeann Phillips, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 22026 20th Ave Se, Bothell, WA 98021 Phone: 425-672-7293    Fax: 425-329-4640

News Archive

Antibiotics for exacerbations of chronic obstructive pulmonary disease

People with chronic obstructive pulmonary disease often experience short term worsening and aggravation of their symptoms.

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer

Advanced Accelerator Applications S.A., a Novartis company and leader in nuclear medicine theragnostics, today announced that the first patients have been dosed in two Phase I/II clinical studies of radiolabeled PSMA-R2, a urea-based ligand of Prostate-Specific Membrane Antigen, which is commonly expressed on prostate cancer cells.

Set of genes identified in human genome essential for survival, proliferation of human cell lines

Using two complementary analytical approaches, scientists at Whitehead Institute and Broad Institute of MIT and Harvard have for the first time identified the universe of genes in the human genome essential for the survival and proliferation of human cell lines or cultured human cells.

Comprehensive gene atlas underlying drug addiction

Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs.

Read more Medical News

› Verified 2 days ago